ID:IOTS - Infectious Disease Insight Of Two Specialists 27. MurDeRing MDR Gram negs. Part 1: AmpC&ESBL
Aug 8, 2022
The podcast delves into the challenges of defining and treating Multi-Drug Resistant Gram-negative infections, comparing guidelines from ESCMID and IDSA. It explores antibiotic efficacy and dosing strategies, especially for treating resistant Enterobacteriaceae. The conversation also touches on the importance of validating resistance susceptibility criteria in microbiology labs.
Chapters
Transcript
Episode notes
1 2 3 4 5 6
Introduction
00:00 • 2min
Challenges in Defining Multi-Drug Resistance
02:25 • 15min
Divergent Guidelines on Antibiotic Treatments
17:15 • 7min
Analysis of Antibiotics Related to Kefir Mysons and Efficacy of Ticker Cycling
23:54 • 4min
Optimizing Antibiotic Therapy for Third-Generation Cephalosporin-Resistant Enterobacteriaceae
27:42 • 13min
Validation and Reporting Practices in Microbiology Labs
40:15 • 3min